Alzheimers & Dementia-Translational Research & Clinical Interventions

Scope & Guideline

Advancing Knowledge, Improving Lives in Dementia Care

Introduction

Delve into the academic richness of Alzheimers & Dementia-Translational Research & Clinical Interventions with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationALZH DEMENT-TRCI / Alzheimers Dement.-Transl. Res. Clin. Interv.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Alzheimers & Dementia: Translational Research & Clinical Interventions' focuses on bridging the gap between basic research and clinical applications in the field of Alzheimer's disease and related dementias. It aims to provide a platform for innovative research that offers insights into the pathophysiology, diagnosis, treatment, and care of Alzheimer's disease.
  1. Clinical Applications of Biomarkers:
    The journal emphasizes research on biomarkers that can aid in the diagnosis and monitoring of Alzheimer's disease. This includes studies on cerebrospinal fluid (CSF) biomarkers, plasma markers, and neuroimaging techniques to track disease progression.
  2. Pharmacological Interventions:
    A significant focus is on the development and evaluation of pharmacological treatments, including anti-amyloid therapies and other disease-modifying agents. This encompasses clinical trials and their design, efficacy, and safety.
  3. Social and Behavioral Aspects of Dementia Care:
    Research related to the psychosocial aspects of dementia care, including caregiver support, patient-centered care strategies, and the impact of social connections on health outcomes is a core area of interest.
  4. Health Disparities and Inclusion:
    The journal addresses issues of diversity and inclusion in Alzheimer's research, emphasizing the importance of studying underrepresented populations and understanding how social determinants affect health outcomes.
  5. Innovative Methodologies:
    The journal promotes the use of novel methods in Alzheimer's research, including machine learning, digital health technologies, and community-based participatory research approaches.
The journal has seen a rise in themes that reflect contemporary issues and advancements in Alzheimer's research. These emerging areas indicate a shift towards more integrative and inclusive approaches to understanding and treating the disease.
  1. Diversity and Inclusion in Research:
    There is an increasing emphasis on the importance of diversity in research populations, addressing health disparities, and ensuring that findings are applicable across different racial, ethnic, and socio-economic groups.
  2. Digital Health Interventions:
    The trend towards digital health solutions, including telehealth, mobile health applications, and online cognitive training programs, is gaining traction as a means to enhance patient engagement and accessibility.
  3. Personalized Medicine Approaches:
    Research that aims to tailor interventions based on individual genetic, biomarker, and lifestyle profiles is on the rise, highlighting a shift towards personalized treatment strategies for Alzheimer's disease.
  4. Holistic and Multidimensional Care Models:
    There is a growing focus on holistic care models that integrate physical, mental, and social health, recognizing the multifaceted nature of dementia and its impact on overall well-being.
  5. Community-Based Participatory Research:
    Increasingly, research methodologies that involve community engagement and collaboration with stakeholders are emerging, reflecting a commitment to addressing real-world challenges faced by individuals with dementia and their caregivers.

Declining or Waning

As the landscape of Alzheimer's research evolves, certain themes within the journal have shown a decline in prominence. This may reflect shifting priorities or advancements in other areas of research.
  1. Traditional Neuropsychological Assessments:
    There appears to be a waning focus on traditional neuropsychological assessments as primary outcomes in Alzheimer's studies, with a shift towards more dynamic and holistic measures of cognition and functionality.
  2. Single-Domain Interventions:
    Research concentrating solely on single-domain interventions, such as cognitive training or pharmacological treatments without integrated approaches, is decreasing as multidisciplinary strategies become more favored.
  3. Cultural Competency Training:
    While once a focal point, specific studies on cultural competency training for dementia care providers are becoming less frequent, possibly as the field moves towards broader systemic changes rather than isolated training programs.
  4. Basic Mechanistic Studies:
    Research centered exclusively on basic mechanistic studies without translational implications is declining, as there is a stronger emphasis on studies that can directly inform clinical practice and patient outcomes.
  5. Epidemiological Studies on Non-Dementia Populations:
    There is a noticeable reduction in studies focusing on the epidemiology of cognitive decline in non-dementia populations, as the journal pivots towards more targeted research on individuals diagnosed with Alzheimer's disease.

Similar Journals

Dementia and Geriatric Cognitive Disorders Extra

Exploring innovative research in geriatric neuroscience.
Publisher: KARGERISSN: Frequency: 3 issues/year

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

Alzheimers Research & Therapy

Connecting researchers to transform Alzheimer's understanding.
Publisher: BMCISSN: Frequency: 1 issue/year

Alzheimer's Research & Therapy is a leading peer-reviewed journal published by BMC, dedicated to advancing our understanding of Alzheimer's disease and other neurodegenerative disorders. As an Open Access journal since 2009, it ensures that vital research findings are freely accessible to the global community, facilitating collaboration and innovation in the field. The journal's commitment to quality is evident in its impressive impact factor and its prestigious ranking in the Q1 quartile across multiple categories including Cognitive Neuroscience and Neurology. With a Scopus rank placing it in the top tier of both Neuroscience and Neurology disciplines, Alzheimer's Research & Therapy serves as a crucial platform for researchers, clinicians, and students who seek to contribute to the fight against Alzheimer's and related disorders. The journal covers a wide range of topics and actively encourages submissions that explore therapeutic strategies and innovative research methodologies, enriching the scientific dialogue in this vital area of health.

Alzheimers & Dementia

Shaping the future of Alzheimer's research and treatment.
Publisher: WILEYISSN: 1552-5260Frequency: 12 issues/year

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.

JAMA Psychiatry

Championing Excellence in Psychiatric Research and Care
Publisher: AMER MEDICAL ASSOCISSN: 2168-622XFrequency: 12 issues/year

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.

Journal of Gerontological Nursing

Exploring the Future of Elderly Care
Publisher: SLACK INCISSN: 0098-9134Frequency: 12 issues/year

The Journal of Gerontological Nursing, published by SLACK INC, is a leading peer-reviewed journal dedicated to advancing the field of gerontological nursing through innovative research, clinical practice, and educational advancements. Since its inception in 1975, this journal has become a crucial resource for researchers, healthcare professionals, and students interested in the care and management of older adults. With an impact factor that reflects its significance within the disciplines of gerontology and nursing (Category Quartiles: Q3 in Gerontology and Q3 in Nursing), it serves as a platform for disseminating vital findings, best practices, and evidence-based approaches aimed at improving the quality of life for the aging population. While the journal maintains a print-only format, its content is invaluable for those looking to stay ahead in the rapidly evolving landscape of gerontological care. As it continues to publish until 2024, the Journal of Gerontological Nursing invites contributions that foster dialogue and innovation within this essential area of healthcare.

Translational Pediatrics

Connecting Laboratory Insights to Clinical Excellence.
Publisher: AME PUBLISHING COMPANYISSN: 2224-4336Frequency: 12 issues/year

Translational Pediatrics is a leading journal in the field of Pediatrics, specializing in bridging the gap between laboratory research and clinical practice. Published by AME Publishing Company in Hong Kong, this journal aims to promote the translation of scientific discoveries into innovative interventions for child health. With its ISSN 2224-4336 and E-ISSN 2224-4344, the journal is accessible to a global audience, enhancing knowledge sharing among researchers, clinicians, and educators. Recognized in 2023 as a Q2 category journal in Pediatrics, Perinatology, and Child Health, it ranks 72nd out of 330 according to Scopus, placing it in the top 22% of its category. With an impactful Convergence of research from 2015 to 2024, Translational Pediatrics is dedicated to providing an essential platform for high-quality studies that advance pediatric care and foster best practices in child health.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Transforming geriatric psychiatry through impactful insights.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

Annals of Geriatric Medicine and Research

Innovating solutions for elderly healthcare.
Publisher: KOREAN GERIATRIC SOCISSN: 2508-4909Frequency: 4 issues/year

Annals of Geriatric Medicine and Research, published by the Korean Geriatric Society, is a premier open-access journal dedicated to advancing the understanding of geriatric medicine and gerontology. Since its inception in 1997, the journal has played a crucial role in disseminating significant research findings, policy discussions, and clinical innovations that address the complexities of elderly healthcare. Based in South Korea, the journal has gained recognition with an impact factor reflecting its Q2 ranking in the field of Geriatrics and Gerontology for 2023, placing it competitively within its category among 116 journals. Researchers, healthcare professionals, and students will find comprehensive insights ranging from clinical studies to public health strategies crucial for enhancing the quality of life of older adults. With a commitment to open access, the journal ensures that its valuable information is freely available, fostering collaboration and knowledge-sharing that is vital in this dynamic field.

Current Geriatrics Reports

Advancing knowledge in the evolving landscape of geriatrics.
Publisher: SPRINGERISSN: Frequency: 4 issues/year

Current Geriatrics Reports is a pivotal journal published by SPRINGER, dedicated to disseminating cutting-edge research and insights in the dynamic field of geriatrics and gerontology. Launched in 2014 and ongoing until 2024, this journal plays a critical role in addressing the complex needs and challenges faced by the aging population. Although it currently holds a Q4 quartile ranking in its category and occupies the 84th position out of 116 in the Scopus metrics for Medicine, Geriatrics, and Gerontology, it serves as a vital platform for emerging research that shapes clinical practices and policy-making. Researchers, professionals, and students alike will find Current Geriatrics Reports to be an invaluable resource for staying updated on advancements, best practices, and innovations in geriatric care. While the journal is not open access, it continues to impact the field significantly and enrich contemporary discussions surrounding aging.

NEUROLOGIST

Empowering Neurology Through Cutting-Edge Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1074-7931Frequency: 6 issues/year

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.